Bristol Myers Squibb announced it will purchase Nvidia's latest DGX SuperPOD based on Vera Rubin systems for AI-driven drug discovery and development, becoming the first life sciences company to acquire the system.
Finnhub07/20, 06:01 PM
Your privacy choice
S7 Markets works without measurement. If you allow it, we count which screens are opened and which actions are taken, on our own domain and never anything you typed. You can change this in Settings at any time.
Read the privacy policyNews story
Finnhub07/20, 06:01 PM